Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Depardieu

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Methods (San Diego, Calif.)|August 5, 2019
Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levelsFlorence Depardieu, David Bikard
Journal of Clinical Microbiology|December 8, 2004
Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCRFlorence Depardieu, Bruno Perichon, Patrice Courvalin
Molecular Microbiology|November 18, 2003
A six amino acid deletion, partially overlapping the VanSB G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faeciumFlorence Depardieu, Patrice Courvalin, Tarek Msadek
Microbiology (Reading, England)|August 27, 1999
Regulated interactions between partner and non-partner sensors and response regulators that control glycopeptide resistance gene expression in enterococciMichel Arthur, Florence Depardieu, Patrice Courvalin
Molecular Microbiology|June 28, 2005
Binding sites of VanRB and sigma70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524Florence Depardieu, Patrice Courvalin, Annie Kolb
Plos Genetics|April 22, 2015
Competition between VanU(G) repressor and VanR(G) activator leads to rheostatic control of vanG vancomycin resistance operon expressionFlorence Depardieu, Vincent Mejean, Patrice Courvalin
Antimicrobial Agents and Chemotherapy|December 25, 2002
VanD-type vancomycin-resistant Enterococcus faecium 10/96AFlorence Depardieu, Peter E Reynolds, Patrice Courvalin
Antimicrobial Agents and Chemotherapy|March 11, 2009
VanB-type Enterococcus faecium clinical isolate successively inducibly resistant to, dependent on, and constitutively resistant to vancomycinAlvaro San Millan, Florence Depardieu, Sylvain Godreuil, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2010
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococciMarie-Laure Foucault, Florence Depardieu, Patrice Courvalin, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faeciumAgnès Lefort, Louis Garry, Florence Depardieu, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Methods (San Diego, Calif.)|August 5, 2019
Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levelsFlorence Depardieu, David Bikard
Journal of Clinical Microbiology|December 8, 2004
Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCRFlorence Depardieu, Bruno Perichon, Patrice Courvalin
Molecular Microbiology|November 18, 2003
A six amino acid deletion, partially overlapping the VanSB G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faeciumFlorence Depardieu, Patrice Courvalin, Tarek Msadek
Microbiology (Reading, England)|August 27, 1999
Regulated interactions between partner and non-partner sensors and response regulators that control glycopeptide resistance gene expression in enterococciMichel Arthur, Florence Depardieu, Patrice Courvalin
Molecular Microbiology|June 28, 2005
Binding sites of VanRB and sigma70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524Florence Depardieu, Patrice Courvalin, Annie Kolb
Plos Genetics|April 22, 2015
Competition between VanU(G) repressor and VanR(G) activator leads to rheostatic control of vanG vancomycin resistance operon expressionFlorence Depardieu, Vincent Mejean, Patrice Courvalin
Antimicrobial Agents and Chemotherapy|December 25, 2002
VanD-type vancomycin-resistant Enterococcus faecium 10/96AFlorence Depardieu, Peter E Reynolds, Patrice Courvalin
Antimicrobial Agents and Chemotherapy|March 11, 2009
VanB-type Enterococcus faecium clinical isolate successively inducibly resistant to, dependent on, and constitutively resistant to vancomycinAlvaro San Millan, Florence Depardieu, Sylvain Godreuil, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2010
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococciMarie-Laure Foucault, Florence Depardieu, Patrice Courvalin, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faeciumAgnès Lefort, Louis Garry, Florence Depardieu, et al.
Pageof 3